Capital Investment Advisors LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 12.1% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,400 shares of the healthcare conglomerate's stock after selling 2,819 shares during the period. Capital Investment Advisors LLC's holdings in UnitedHealth Group were worth $6,364,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Brighton Jones LLC boosted its holdings in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC boosted its holdings in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after buying an additional 2,324 shares during the period. Baker Tilly Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 5.4% during the first quarter. Baker Tilly Wealth Management LLC now owns 1,276 shares of the healthcare conglomerate's stock worth $668,000 after purchasing an additional 65 shares during the period. Fiduciary Alliance LLC boosted its holdings in shares of UnitedHealth Group by 2.8% during the first quarter. Fiduciary Alliance LLC now owns 10,172 shares of the healthcare conglomerate's stock worth $5,328,000 after purchasing an additional 279 shares during the period. Finally, NBC Securities Inc. boosted its holdings in shares of UnitedHealth Group by 71,127.3% during the first quarter. NBC Securities Inc. now owns 7,835 shares of the healthcare conglomerate's stock worth $4,103,000 after purchasing an additional 7,824 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.
UnitedHealth Group Trading Up 0.2%
Shares of UNH stock opened at $344.61 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm's fifty day simple moving average is $302.45 and its 200 day simple moving average is $357.73. The firm has a market capitalization of $312.10 billion, a P/E ratio of 14.93, a price-to-earnings-growth ratio of 2.24 and a beta of 0.45. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same period last year, the firm posted $6.80 EPS. The company's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. UnitedHealth Group's payout ratio is currently 38.30%.
Analyst Ratings Changes
Several research firms recently commented on UNH. Oppenheimer decreased their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Truist Financial raised their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a report on Tuesday, September 9th. Royal Bank Of Canada cut their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. JPMorgan Chase & Co. cut their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 6th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $440.00 price objective on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus price target of $358.95.
Check Out Our Latest Report on UnitedHealth Group
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.